Harrow Health Inc
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, … Read more
Harrow Health Inc (HROW) - Total Assets
Latest total assets as of September 2025: $363.07 Million USD
Based on the latest financial reports, Harrow Health Inc (HROW) holds total assets worth $363.07 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Harrow Health Inc - Total Assets Trend (2005–2024)
This chart illustrates how Harrow Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Harrow Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Harrow Health Inc's total assets of $363.07 Million consist of 48.8% current assets and 51.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.2% |
| Accounts Receivable | $116.60 Million | 30.0% |
| Inventory | $10.70 Million | 2.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $186.70 Million | 48.0% |
| Goodwill | $332.00K | 0.1% |
Asset Composition Trend (2005–2024)
This chart illustrates how Harrow Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Harrow Health Inc's current assets represent 48.8% of total assets in 2024, a decrease from 100.0% in 2005.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2024, down from 100.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 48.0% of total assets.
Harrow Health Inc Competitors by Total Assets
Key competitors of Harrow Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Harrow Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Harrow Health Inc generates 0.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Harrow Health Inc is currently not profitable relative to its asset base.
Harrow Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 1.55 | 3.79 |
| Quick Ratio | 2.52 | 1.44 | 3.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $112.20 Million | $ 52.06 Million | $ 30.18 Million |
Harrow Health Inc - Advanced Valuation Insights
This section examines the relationship between Harrow Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 37.57 |
| Latest Market Cap to Assets Ratio | 2.46 |
| Asset Growth Rate (YoY) | 24.8% |
| Total Assets | $388.97 Million |
| Market Capitalization | $956.53 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Harrow Health Inc's assets at a significant premium ( 2.46x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Harrow Health Inc's assets grew by 24.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Harrow Health Inc (2005–2024)
The table below shows the annual total assets of Harrow Health Inc from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $388.97 Million | +24.77% |
| 2023-12-31 | $311.75 Million | +98.54% |
| 2022-12-31 | $157.02 Million | +59.69% |
| 2021-12-31 | $98.33 Million | +71.08% |
| 2020-12-31 | $57.47 Million | -2.73% |
| 2019-12-31 | $59.09 Million | +19.48% |
| 2018-12-31 | $49.45 Million | +106.76% |
| 2017-12-31 | $23.92 Million | -12.22% |
| 2016-12-31 | $27.25 Million | +92.82% |
| 2015-12-31 | $14.13 Million | +37.97% |
| 2014-12-31 | $10.24 Million | -35.02% |
| 2013-12-31 | $15.76 Million | +47.22% |
| 2012-12-31 | $10.71 Million | +6551.46% |
| 2011-12-31 | $160.96K | -54.31% |
| 2010-12-31 | $352.29K | -78.93% |
| 2009-12-31 | $1.67 Million | -68.66% |
| 2008-12-31 | $5.34 Million | +25.82% |
| 2007-12-31 | $4.24 Million | +16706.92% |
| 2006-12-31 | $25.23K | -36.83% |
| 2005-12-31 | $39.94K | -- |